Esperion Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 38 U.S.-traded ETFs. ESPR has around 2.7M shares in the U.S. ETF market. The largest ETF holder of ESPR is the SPDR S&P Biotech ETF (XBI), with approximately 923.08K shares. Investors may also find of interest that the ETF with the largest allocation to ESPR stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 1.76%. On average, U.S. ETFs allocate 0.21% of ESPR to their portfolios.
Additionally, ESPR is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ESPR as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.